Aurinia Pharmaceuticals Inc (AUPH)

EBITDA

$188.22M

TTM · Period ending: · USD

AUPH logo

AUPH EBITDA

Latest reported$188.22M
AUPH TTM EBITDA (-$1.02M → $188.22M)
High-resolution chart · PNG

AUPH ebitda history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Aurinia Pharmaceuticals Inc EBITDA — Trailing twelve months (TTM) (USD)
Period endingEBITDA (USD)
-7,835,776
-6,357,693
-4,336,415
-2,910,849
-1,647,738
-1,022,254
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.